Sterling Investment Advisors Ltd. Acquires 9,008 Shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)

Sterling Investment Advisors Ltd. boosted its position in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 5.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 167,703 shares of the company’s stock after acquiring an additional 9,008 shares during the period. Tema Cardiovascular and Metabolics ETF accounts for 1.2% of Sterling Investment Advisors Ltd.’s portfolio, making the stock its 24th largest position. Sterling Investment Advisors Ltd. owned 7.29% of Tema Cardiovascular and Metabolics ETF worth $4,842,000 at the end of the most recent reporting period.

Tema Cardiovascular and Metabolics ETF Trading Down 0.2 %

Shares of HRTS opened at $30.66 on Tuesday. The stock has a market cap of $70.52 million, a P/E ratio of 32.89 and a beta of 0.93. The stock’s 50-day moving average price is $29.74 and its two-hundred day moving average price is $32.11. Tema Cardiovascular and Metabolics ETF has a 1 year low of $28.56 and a 1 year high of $36.03.

Tema Cardiovascular and Metabolics ETF Announces Dividend

The company also recently announced a dividend, which was paid on Thursday, December 12th. Investors of record on Wednesday, December 11th were given a $0.4693 dividend. The ex-dividend date of this dividend was Wednesday, December 11th.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.